aMe17c (R), n=2 cell(s)

Main group: Visual Centrifugal Neurons; Neurotransmitter consensus prediction: Glu

Mean synapse counts per layer

  LA
Post -
Pre -
  M1 M2 M3 M4 M5 M6 M7 M8 M9 M10 Total
0 - - 273.0 392.0 67.0 65.0 20.0 2.0 - - 819
1 - - 2072.0 1821.0 357.5 47.0 5.5 3.0 - - 4306
  LO1 LO2 LO3 LO4 LO5a LO5b LO6 Total
Post - - - - - 2.5 118.5 121.0
Pre - - - - - - - -
  AME
0 175
1 11
  LOP1 LOP2 LOP3 LOP4 Total
Post - - - - -
Pre - - - - -
  central brain
0 1448.0
1 11.5

Neuron visualizations

Population spatial coverage

Medulla

Number of post synapses:1638
Number of pre synapses:8612
Number of output connections:30153
Coverage factor:1.4
Columnar completeness:0.93
Area completeness:1.00
Cell size (columns):599

Lobula

Number of post synapses:242
Number of pre synapses:0
Number of output connections:0
Coverage factor:1.1
Columnar completeness:0.11
Area completeness:0.37
Cell size (columns):54

Lobula Plate

Number of post synapses:0
Number of pre synapses:0
Number of output connections:0
Coverage factor:0
Columnar completeness:0
Area completeness:0
Cell size (columns):0

Optic Lobe Connectivity

Inputs

  instance NT total connections connections /#aMe17c (R) % % cumu.
0 Mi4 (R) GABA 717 358.5 26.9% 26.9%
1 MeVPaMe1 (L) ACh 256 128.0 9.6% 36.5%
2 aMe1 (R) GABA 215 107.5 8.1% 44.6%
3 TmY18 (R) ACh 143 71.5 5.4% 49.9%
4 MeVPaMe1 (R) ACh 102 51.0 3.8% 53.8%
5 Tm16 (R) ACh 92 46.0 3.5% 57.2%
6 Mi1 (R) ACh 78 39.0 2.9% 60.1%
7 aMe3 (R) Glu 64 32.0 2.4% 62.5%
8 Lawf1 (R) ACh 59 29.5 2.2% 64.7%
9 OCG02c (L) unclear 50 25.0 1.9% 66.6%
10 Cm5 (R) GABA 49 24.5 1.8% 68.5%
11 MeVP62 (R) ACh 46 23.0 1.7% 70.2%
12 Dm10 (R) GABA 41 20.5 1.5% 71.7%
13 Cm8 (R) GABA 38 19.0 1.4% 73.1%
14 Cm21 (R) GABA 30 15.0 1.1% 74.3%
15 Mi9 (R) Glu 29 14.5 1.1% 75.4%
16 Tm3 (R) ACh 29 14.5 1.1% 76.4%
17 Mi10 (R) ACh 25 12.5 0.9% 77.4%
18 C3 (R) GABA 23 11.5 0.9% 78.2%
19 OA-AL2i1 (R) OA 19 9.5 0.7% 79.0%
20 Dm12 (R) Glu 18 9.0 0.7% 79.6%
21 LoVP96 (R) Glu 16 8.0 0.6% 80.2%
22 OCG02c (R) unclear 15 7.5 0.6% 80.8%
23 TmY3 (R) ACh 13 6.5 0.5% 81.3%
24 L5 (R) ACh 12 6.0 0.5% 81.7%
25 MeVP38 (R) ACh 12 6.0 0.5% 82.2%
26 TmY17 (R) ACh 12 6.0 0.5% 82.6%
27 5-HTPMPV03 (R) 5HT 11 5.5 0.4% 83.0%
28 aMe6a (R) ACh 11 5.5 0.4% 83.5%
29 MeLo3b (R) ACh 11 5.5 0.4% 83.9%
30 TmY14 (R) Glu 11 5.5 0.4% 84.3%
31 TmY15 (R) GABA 11 5.5 0.4% 84.7%
32 Dm13 (R) GABA 10 5.0 0.4% 85.1%
33 Dm20 (R) Glu 10 5.0 0.4% 85.4%
34 L4 (R) ACh 10 5.0 0.4% 85.8%
35 MeVC22 (R) Glu 10 5.0 0.4% 86.2%
36 Tm37 (R) Glu 10 5.0 0.4% 86.6%
37 Cm31b (R) GABA 9 4.5 0.3% 86.9%
38 Mi18 (R) GABA 9 4.5 0.3% 87.2%
39 aMe2 (R) Glu 8 4.0 0.3% 87.5%
40 MeVC11 (L) ACh 8 4.0 0.3% 87.8%
41 MeVP29 (R) ACh 8 4.0 0.3% 88.1%
42 Dm2 (R) ACh 7 3.5 0.3% 88.4%
43 MeVCMe1 (R) ACh 7 3.5 0.3% 88.7%
44 Tm4 (R) ACh 7 3.5 0.3% 88.9%
45 aMe30 (R) Glu 6 3.0 0.2% 89.2%
46 LPT51 (R) Glu 6 3.0 0.2% 89.4%
47 MeVP11 (R) ACh 6 3.0 0.2% 89.6%
48 MeVPMe2 (R) Glu 6 3.0 0.2% 89.8%
49 Tm38 (R) ACh 6 3.0 0.2% 90.1%
50 TmY13 (R) ACh 6 3.0 0.2% 90.3%
51 aMe4 (R) ACh 5 2.5 0.2% 90.5%
52 aMe6b (R) ACh 5 2.5 0.2% 90.7%
53 Cm9 (R) Glu 5 2.5 0.2% 90.8%
54 MeVCMe1 (L) ACh 5 2.5 0.2% 91.0%
55 MeVPaMe2 (L) Glu 5 2.5 0.2% 91.2%
56 MeVPMe2 (L) Glu 5 2.5 0.2% 91.4%
57 5-HTPMPV03 (L) 5HT 4 2.0 0.2% 91.6%
58 5thsLNv_LNd6 (R) ACh 4 2.0 0.2% 91.7%
59 aMe5 (R) ACh 4 2.0 0.2% 91.9%
60 aMe8 (R) ACh 4 2.0 0.2% 92.0%
61 Dm9 (R) Glu 4 2.0 0.2% 92.2%
62 LoVP72 (R) ACh 4 2.0 0.2% 92.3%
63 MeLo3a (R) ACh 4 2.0 0.2% 92.5%
64 MeLo6 (R) ACh 4 2.0 0.2% 92.6%
65 MeTu1 (R) ACh 4 2.0 0.2% 92.8%
66 MeVPLo2 (R) ACh 4 2.0 0.2% 92.9%
67 Mi15 (R) ACh 4 2.0 0.2% 93.1%
68 OA-AL2i4 (R) OA 4 2.0 0.2% 93.2%
69 Tm2 (R) ACh 4 2.0 0.2% 93.4%
70 Tm39 (R) ACh 4 2.0 0.2% 93.5%
71 Tm5c (R) Glu 4 2.0 0.2% 93.7%
72 TmY5a (R) Glu 4 2.0 0.2% 93.8%
73 aMe17b (R) GABA 3 1.5 0.1% 93.9%
74 aMe17c (R) Glu 3 1.5 0.1% 94.0%
75 Cm12 (R) GABA 3 1.5 0.1% 94.1%
76 Cm3 (R) GABA 3 1.5 0.1% 94.3%
77 Dm4 (R) Glu 3 1.5 0.1% 94.4%
78 L3 (R) ACh 3 1.5 0.1% 94.5%
79 MeLo1 (R) ACh 3 1.5 0.1% 94.6%
80 MeLo13 (R) Glu 3 1.5 0.1% 94.7%
81 MeLo2 (R) ACh 3 1.5 0.1% 94.8%
82 MeTu4a (R) ACh 3 1.5 0.1% 94.9%
83 MeTu4f (R) ACh 3 1.5 0.1% 95.0%
84 MeVP18 (R) unclear 3 1.5 0.1% 95.2%
85 MeVPMe11 (L) Glu 3 1.5 0.1% 95.3%
86 Mi14 (R) Glu 3 1.5 0.1% 95.4%
87 PS272 (L) unclear 3 1.5 0.1% 95.5%
88 T2a (R) ACh 3 1.5 0.1% 95.6%
89 aMe12 (R) ACh 2 1.0 0.1% 95.7%
90 aMe22 (R) Glu 2 1.0 0.1% 95.8%
91 Cm15 (R) GABA 2 1.0 0.1% 95.8%
92 Cm24 (R) Glu 2 1.0 0.1% 95.9%
93 Cm25 (R) Glu 2 1.0 0.1% 96.0%
94 Cm33 (R) GABA 2 1.0 0.1% 96.1%
95 DNc01 (L) unclear 2 1.0 0.1% 96.1%
96 l-LNv (R) unclear 2 1.0 0.1% 96.2%
97 LAL047 (R) GABA 2 1.0 0.1% 96.3%
98 LC10b (R) ACh 2 1.0 0.1% 96.4%
99 LC41 (R) ACh 2 1.0 0.1% 96.4%
100 Li14 (R) Glu 2 1.0 0.1% 96.5%
101 LoVC22 (L) Dop 2 1.0 0.1% 96.6%
102 LoVC23 (L) GABA 2 1.0 0.1% 96.7%
103 LT63 (R) ACh 2 1.0 0.1% 96.7%
104 MeLo7 (R) ACh 2 1.0 0.1% 96.8%
105 MeTu3b (R) ACh 2 1.0 0.1% 96.9%
106 MeTu3c (R) ACh 2 1.0 0.1% 97.0%
107 MeVC21 (R) Glu 2 1.0 0.1% 97.0%
108 MeVP12 (R) ACh 2 1.0 0.1% 97.1%
109 MeVP14 (R) ACh 2 1.0 0.1% 97.2%
110 MeVP4 (R) ACh 2 1.0 0.1% 97.3%
111 MeVP52 (R) ACh 2 1.0 0.1% 97.3%
112 MeVPaMe2 (R) Glu 2 1.0 0.1% 97.4%
113 MeVPMe4 (L) Glu 2 1.0 0.1% 97.5%
114 TmY10 (R) ACh 2 1.0 0.1% 97.6%

Outputs

  instance NT total connections connections /#aMe17c (R) % % cumu.
0 Dm10 (R) GABA 13,235 6,617.5 43.8% 43.8%
1 Dm12 (R) Glu 4,918 2,459.0 16.3% 60.1%
2 TmY15 (R) GABA 2,268 1,134.0 7.5% 67.6%
3 Mi14 (R) Glu 2,124 1,062.0 7.0% 74.6%
4 Tm5c (R) Glu 1,956 978.0 6.5% 81.1%
5 TmY14 (R) Glu 1,575 787.5 5.2% 86.3%
6 Tm3 (R) ACh 679 339.5 2.2% 88.5%
7 TmY18 (R) ACh 623 311.5 2.1% 90.6%
8 Mi10 (R) ACh 450 225.0 1.5% 92.1%
9 TmY19a (R) GABA 395 197.5 1.3% 93.4%
10 C2 (R) GABA 338 169.0 1.1% 94.5%
11 Lawf1 (R) ACh 175 87.5 0.6% 95.1%
12 TmY3 (R) ACh 120 60.0 0.4% 95.5%
13 T2 (R) ACh 107 53.5 0.4% 95.8%
14 Tm36 (R) ACh 97 48.5 0.3% 96.2%
15 Cm11a (R) ACh 86 43.0 0.3% 96.4%
16 Mi18 (R) GABA 81 40.5 0.3% 96.7%
17 Mi4 (R) GABA 77 38.5 0.3% 97.0%
18 Mi16 (R) GABA 62 31.0 0.2% 97.2%
19 TmY13 (R) ACh 49 24.5 0.2% 97.3%
20 Dm20 (R) Glu 32 16.0 0.1% 97.4%
21 Tm29 (R) Glu 31 15.5 0.1% 97.5%
22 Mi1 (R) ACh 30 15.0 0.1% 97.6%
23 Cm7 (R) Glu 27 13.5 0.1% 97.7%
24 Tm16 (R) ACh 26 13.0 0.1% 97.8%
25 MeLo3a (R) ACh 23 11.5 0.1% 97.9%
26 TmY10 (R) ACh 21 10.5 0.1% 98.0%
27 MeVPMe12 (R) ACh 20 10.0 0.1% 98.0%
28 L3 (R) ACh 19 9.5 0.1% 98.1%
29 Tm37 (R) Glu 19 9.5 0.1% 98.2%
30 Mi9 (R) Glu 18 9.0 0.1% 98.2%
31 Tm5a (R) ACh 17 8.5 0.1% 98.3%
32 TmY9b (R) ACh 17 8.5 0.1% 98.3%
33 Cm35 (R) GABA 16 8.0 0.1% 98.4%
34 Mi15 (R) ACh 16 8.0 0.1% 98.4%
35 OA-AL2i1 (R) OA 16 8.0 0.1% 98.5%
36 Tm6 (R) ACh 16 8.0 0.1% 98.5%
37 aMe4 (R) ACh 14 7.0 0.0% 98.6%
38 Dm2 (R) ACh 14 7.0 0.0% 98.6%
39 Tm38 (R) ACh 14 7.0 0.0% 98.7%
40 Tm9 (R) ACh 14 7.0 0.0% 98.7%
41 TmY9a (R) ACh 14 7.0 0.0% 98.8%
42 Cm3 (R) GABA 12 6.0 0.0% 98.8%
43 Tm4 (R) ACh 12 6.0 0.0% 98.9%
44 MeLo2 (R) ACh 11 5.5 0.0% 98.9%
45 Mi17 (R) GABA 11 5.5 0.0% 98.9%
46 Tm26 (R) ACh 11 5.5 0.0% 99.0%
47 TmY19b (R) GABA 11 5.5 0.0% 99.0%
48 TmY5a (R) Glu 11 5.5 0.0% 99.0%
49 aMe2 (R) Glu 10 5.0 0.0% 99.1%
50 LC14b (L) ACh 10 5.0 0.0% 99.1%
51 Mi2 (R) Glu 10 5.0 0.0% 99.1%
52 Tm39 (R) ACh 10 5.0 0.0% 99.2%
53 Cm11b (R) ACh 9 4.5 0.0% 99.2%
54 MeVPMe2 (L) Glu 9 4.5 0.0% 99.2%
55 MeVPMe2 (R) Glu 9 4.5 0.0% 99.3%
56 Tm5b (R) ACh 9 4.5 0.0% 99.3%
57 Dm3a (R) Glu 8 4.0 0.0% 99.3%
58 MeVC20 (R) Glu 8 4.0 0.0% 99.3%
59 Tm31 (R) Glu 8 4.0 0.0% 99.4%
60 MeVP11 (R) ACh 7 3.5 0.0% 99.4%
61 C3 (R) GABA 6 3.0 0.0% 99.4%
62 Dm4 (R) Glu 6 3.0 0.0% 99.4%
63 Cm1 (R) ACh 5 2.5 0.0% 99.4%
64 Dm9 (R) Glu 5 2.5 0.0% 99.5%
65 Tm1 (R) ACh 5 2.5 0.0% 99.5%
66 Tm20 (R) ACh 5 2.5 0.0% 99.5%
67 Tm5Y (R) ACh 5 2.5 0.0% 99.5%
68 5-HTPMPV03 (L) 5HT 4 2.0 0.0% 99.5%
69 5-HTPMPV03 (R) 5HT 4 2.0 0.0% 99.5%
70 aMe1 (R) GABA 4 2.0 0.0% 99.5%
71 Cm8 (R) GABA 4 2.0 0.0% 99.6%
72 L5 (R) ACh 4 2.0 0.0% 99.6%
73 Tm12 (R) ACh 4 2.0 0.0% 99.6%
74 TmY4 (R) ACh 4 2.0 0.0% 99.6%
75 5thsLNv_LNd6 (R) ACh 3 1.5 0.0% 99.6%
76 aMe17c (R) Glu 3 1.5 0.0% 99.6%
77 AN09A005 (R) unclear 3 1.5 0.0% 99.6%
78 MeVC_unclear (R) Glu 3 1.5 0.0% 99.6%
79 MeVP51 (R) Glu 3 1.5 0.0% 99.7%
80 MeVPMe3 (R) Glu 3 1.5 0.0% 99.7%
81 MeVPOL1 (R) ACh 3 1.5 0.0% 99.7%
82 Pm3 (R) GABA 3 1.5 0.0% 99.7%
83 Tm2 (R) ACh 3 1.5 0.0% 99.7%
84 aMe12 (R) ACh 2 1.0 0.0% 99.7%
85 aMe15 (R) unclear 2 1.0 0.0% 99.7%
86 aMe17a (R) Glu 2 1.0 0.0% 99.7%
87 aMe17b (R) GABA 2 1.0 0.0% 99.7%
88 aMe30 (R) Glu 2 1.0 0.0% 99.7%
89 CL125 (R) unclear 2 1.0 0.0% 99.7%
90 Cm23 (R) Glu 2 1.0 0.0% 99.7%
91 Cm25 (R) Glu 2 1.0 0.0% 99.7%
92 Cm30 (R) GABA 2 1.0 0.0% 99.8%
93 Dm13 (R) GABA 2 1.0 0.0% 99.8%
94 Dm16 (R) Glu 2 1.0 0.0% 99.8%
95 Dm3b (R) Glu 2 1.0 0.0% 99.8%
96 Dm8a (R) Glu 2 1.0 0.0% 99.8%
97 L1 (R) Glu 2 1.0 0.0% 99.8%
98 L4 (R) ACh 2 1.0 0.0% 99.8%
99 Lawf2 (R) ACh 2 1.0 0.0% 99.8%
100 MeLo6 (R) ACh 2 1.0 0.0% 99.8%
101 MeVC22 (R) Glu 2 1.0 0.0% 99.8%
102 MeVP1 (R) ACh 2 1.0 0.0% 99.8%
103 MeVP12 (R) ACh 2 1.0 0.0% 99.8%
104 MeVP15 (R) ACh 2 1.0 0.0% 99.8%
105 MeVP17 (R) Glu 2 1.0 0.0% 99.8%
106 MeVP2 (R) ACh 2 1.0 0.0% 99.8%
107 MeVP4 (R) ACh 2 1.0 0.0% 99.9%
108 MeVP63 (R) GABA 2 1.0 0.0% 99.9%
109 MeVPLo2 (R) ACh 2 1.0 0.0% 99.9%
110 Mi13 (R) Glu 2 1.0 0.0% 99.9%
111 SLP250 (R) unclear 2 1.0 0.0% 99.9%
112 TmY21 (R) ACh 2 1.0 0.0% 99.9%